ProShare Advisors’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-696
| Closed | -$12.1K | – | 1861 |
|
|
2024
Q1 | $12.1K | Buy |
696
+55
| +9% | +$954 | ﹤0.01% | 1989 |
|
|
2023
Q4 | $8.22K | Sell |
641
-127
| -17% | -$1.63K | ﹤0.01% | 1946 |
|
|
2023
Q3 | $28.4K | Buy |
768
+17
| +2% | +$629 | ﹤0.01% | 1765 |
|
|
2023
Q2 | $30.2K | Buy |
751
+41
| +6% | +$1.65K | ﹤0.01% | 1813 |
|
|
2023
Q1 | $51.5K | Sell |
710
-81
| -10% | -$5.87K | ﹤0.01% | 1668 |
|
|
2022
Q4 | $64.9K | Buy |
791
+65
| +9% | +$5.33K | ﹤0.01% | 1710 |
|
|
2022
Q3 | $69K | Buy |
726
+23
| +3% | +$2.19K | ﹤0.01% | 1618 |
|
|
2022
Q2 | $137K | Sell |
703
-334
| -32% | -$65.1K | ﹤0.01% | 1553 |
|
|
2022
Q1 | $241K | Sell |
1,037
-220
| -18% | -$51.1K | ﹤0.01% | 1771 |
|
|
2021
Q4 | $495K | Buy |
1,257
+109
| +9% | +$42.9K | ﹤0.01% | 1450 |
|
|
2021
Q3 | $514K | Sell |
1,148
-314
| -21% | -$141K | ﹤0.01% | 1200 |
|
|
2021
Q2 | $568K | Buy |
1,462
+147
| +11% | +$57.1K | ﹤0.01% | 1440 |
|
|
2021
Q1 | $472K | Buy |
1,315
+165
| +14% | +$59.2K | ﹤0.01% | 1480 |
|
|
2020
Q4 | $565K | Buy |
1,150
+316
| +38% | +$155K | ﹤0.01% | 1184 |
|
|
2020
Q3 | $270K | Buy |
834
+64
| +8% | +$20.7K | ﹤0.01% | 1241 |
|
|
2020
Q2 | $280K | Buy |
770
+352
| +84% | +$128K | ﹤0.01% | 1263 |
|
|
2020
Q1 | $89K | Sell |
418
-330
| -44% | -$70.3K | ﹤0.01% | 1090 |
|
|
2019
Q4 | $308K | Sell |
748
-68
| -8% | -$28K | ﹤0.01% | 1329 |
|
|
2019
Q3 | $288K | Buy |
816
+98
| +14% | +$34.6K | ﹤0.01% | 1254 |
|
|
2019
Q2 | $361K | Sell |
718
-92
| -11% | -$46.3K | ﹤0.01% | 1149 |
|
|
2019
Q1 | $805K | Buy |
810
+14
| +2% | +$13.9K | ﹤0.01% | 857 |
|
|
2018
Q4 | $691K | Sell |
796
-149
| -16% | -$129K | ﹤0.01% | 824 |
|
|
2018
Q3 | $977K | Sell |
945
-8
| -0.8% | -$8.27K | 0.01% | 826 |
|
|
2018
Q2 | $876K | Buy |
953
+67
| +8% | +$61.6K | 0.01% | 885 |
|
|
2018
Q1 | $864K | Buy |
886
+68
| +8% | +$66.3K | 0.01% | 883 |
|
|
2017
Q4 | $370K | Buy |
818
+59
| +8% | +$26.7K | ﹤0.01% | 1275 |
|
|
2017
Q3 | $314K | Buy |
759
+71
| +10% | +$29.4K | ﹤0.01% | 1120 |
|
|
2017
Q2 | $241K | Sell |
688
-35
| -5% | -$12.3K | ﹤0.01% | 1268 |
|
|
2017
Q1 | $372K | Sell |
723
-189
| -21% | -$97.2K | ﹤0.01% | 1137 |
|
|
2016
Q4 | $324K | Buy |
912
+94
| +11% | +$33.4K | ﹤0.01% | 1317 |
|
|
2016
Q3 | $438K | Sell |
818
-151
| -16% | -$80.9K | 0.01% | 997 |
|
|
2016
Q2 | $546K | Buy |
969
+39
| +4% | +$22K | 0.01% | 929 |
|
|
2016
Q1 | $443K | Sell |
930
-89
| -9% | -$42.4K | 0.01% | 1053 |
|
|
2015
Q4 | $673K | Buy |
+1,019
| New | +$673K | 0.01% | 906 |
|